Polyclonal Antibody News and Research

RSS
Bird flu virus detected in Alaskan polar bear

Bird flu virus detected in Alaskan polar bear

Redefining the battle against Alzheimer's with tau-focused treatments

Redefining the battle against Alzheimer's with tau-focused treatments

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Advances in influenza research

Advances in influenza research

Breakthrough: Sequencing functional antibody proteins directly from human blood

Breakthrough: Sequencing functional antibody proteins directly from human blood

Protein Medin: A new treatment target for Alzheimer's

Protein Medin: A new treatment target for Alzheimer's

Sheep milk could be an inexpensive source of therapeutic polyclonal SARS-CoV-2 neutralizing antibodies

Sheep milk could be an inexpensive source of therapeutic polyclonal SARS-CoV-2 neutralizing antibodies

Vaccine-induced neutralizing and non-neutralizing antibody activity against SARS-CoV-2

Vaccine-induced neutralizing and non-neutralizing antibody activity against SARS-CoV-2

How do BNT162b2 vaccine-induced neutralizing and non-neutralizing antibodies synergize to promote protection against SARS-CoV-2?

How do BNT162b2 vaccine-induced neutralizing and non-neutralizing antibodies synergize to promote protection against SARS-CoV-2?

Antibody evasion of Omicron BA.2.75 is less pronounced than BA.4/5

Antibody evasion of Omicron BA.2.75 is less pronounced than BA.4/5

Study tests equine polyclonal antibodies against SARS-CoV-2 variants

Study tests equine polyclonal antibodies against SARS-CoV-2 variants

Doggybone DNA COVID-19 vaccine can effectively neutralize SARS-CoV-2 variants

Doggybone DNA COVID-19 vaccine can effectively neutralize SARS-CoV-2 variants

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

Study describes ultra-structure of Nipah virus surface glycoprotein

Study describes ultra-structure of Nipah virus surface glycoprotein

Role of natural immunity to SARS-CoV-2 on post-vaccination antibody responses in staff and residents of long-term care facilities

Role of natural immunity to SARS-CoV-2 on post-vaccination antibody responses in staff and residents of long-term care facilities

SARS-CoV-2 Delta variant-induced antibody response largely focuses on class 1 and 2 antibody epitopes

SARS-CoV-2 Delta variant-induced antibody response largely focuses on class 1 and 2 antibody epitopes

Encouraging in vitro results with SARS-CoV-2-spike-specific polyclonal antibody fragments

Encouraging in vitro results with SARS-CoV-2-spike-specific polyclonal antibody fragments

Study shows IgA antibodies play a significant role in neutralizing SARS-CoV-2

Study shows IgA antibodies play a significant role in neutralizing SARS-CoV-2

Assessing the neutralizing ability of polyclonal antibody XAV-19 against SARS-CoV-2 Omicron variant

Assessing the neutralizing ability of polyclonal antibody XAV-19 against SARS-CoV-2 Omicron variant

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.